Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03695146 · ClinicalTrials.gov registry record · NA

Heart Inflammation and Mental Stress Study

A NA study of Hypertension, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT03695146: Completed NA study of Hypertension, sponsored by University of Miami.

NCT03695146 is a NA study of Hypertension that has completed, run by University of Miami. The registered enrollment target is 52 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03695146, a NA study of Hypertension, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The aim of the study is to investigate the neural underpinnings of cardiovascular reactivity to mental stress as a function of HIV and hypertensive risk.

Primary Outcome

Heart rate variability will be measured using a standard electrocardiogram to detect variability in R -to-R intervals.

Conditions Studied

Interventions

  • BEHAVIORAL Paced breathing
  • BEHAVIORAL Active relaxation

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2019-08-19
Est. Completion 2023-12-22
Phase NA
University of Miami

721 total trials

What the finished NCT03695146 record still lists

NCT03695146 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Paced breathing is the first listed.

NCT03695146 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03695146 about?

NCT03695146 is a clinical study titled "Heart Inflammation and Mental Stress Study". The aim of the study is to investigate the neural underpinnings of cardiovascular reactivity to mental stress as a function of HIV and hypertensive risk.

What is the current status of trial NCT03695146?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2019-08-19. Estimated completion is 2023-12-22.

What conditions does trial NCT03695146 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT03695146?

The interventions under investigation include: Paced breathing (BEHAVIORAL), Active relaxation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03695146?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03695146 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03695146's enrollment target sits among peer trials

52 365th of 470 higher than 105 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03695146, the US trial registry maintained by the National Library of Medicine. NCT03695146 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.